One Nucleus – Genesis 2016

It’s pharmaceutical crystal ball time. There was an interesting debate on what will drive growth in the Pharma industry in the 21st century debated by a distinguished panel. Their thoughts were gene therapies and advanced biologics will come of age as we have seen with MAB’s and the possibility of generic gene therapies was discussed. The other area of debate was around med tech and how the likes of Google will become further involved in Pharma and potentially go on  the acquisition trail. As always an interesting debate and good to catch up with leaders in the industry. PiR is looking forward to Genesis 2017 to see how things evolve in the next 12 months.

One Nucleus Genesis

One Nucleus Genesis

 

 

Comments are closed.